Posted in | News | Imaging | Medical Optics

Bruker All Set to Take Over the Pre-clinical In-vivo Imaging Business of Carestream

Bruker and Carestream Health have signed a contract which will enable Bruker to acquire the pre-clinical in-vivo imaging equipment and associated assets from Carestream’s Molecular Imaging enterprise.

Bruker is a supplier of high-performance scientific equipment and solutions for materials and molecular research, and also for applied and industrial studies. Carestream Health is a global provider of x-ray films and digital x-ray setups for non-destructive imaging; sophisticated products for the precision films and electronics markets; and medical and dental imaging systems and healthcare IT solutions. Financial conditions of the contract are being kept under wraps. As per the conditions of the contract, most of the Carestream pre-clinical in-vivo imaging personnel will be given an option to be a part of Bruker. The contract will be concluded in the coming weeks.

Carestream will hold on to the remaining assets of its Molecular Imaging enterprise, inclusive of its life-science x-ray films merchandise assortment as well as its Gel Logic and Image Station in-vitro imaging equipment merchandise portfolio. Carestream will continue to its life-science x-ray film business, and will go on providing assistance to its in-vitro goods customers with spare parts and services. Its Gel Logic and Image Station in-vitro merchandise will no longer be produced.

The President of BrukerBioSpin, Dr Werner Mass stated that the organization is pleased with the addition of Carestream in-vivo imaging systems to Bruker’s pre-clinical imaging merchandise portfolio. He added that Carestream’s optical molecular imaging equipment will supplement Bruker’s other pre-clinical solutions, which currently include magnetic particle imaging (MPI), x-ray micro-computed chromatography (microCT) and magnetic resonance imaging (MRI). He also extended a warm welcome to Carestream employees who will be a part of Bruker and looked forward to their quality services.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 27). Bruker All Set to Take Over the Pre-clinical In-vivo Imaging Business of Carestream. AZoOptics. Retrieved on November 23, 2024 from https://www.azooptics.com/News.aspx?newsID=16163.

  • MLA

    Thomas, G.P.. "Bruker All Set to Take Over the Pre-clinical In-vivo Imaging Business of Carestream". AZoOptics. 23 November 2024. <https://www.azooptics.com/News.aspx?newsID=16163>.

  • Chicago

    Thomas, G.P.. "Bruker All Set to Take Over the Pre-clinical In-vivo Imaging Business of Carestream". AZoOptics. https://www.azooptics.com/News.aspx?newsID=16163. (accessed November 23, 2024).

  • Harvard

    Thomas, G.P.. 2019. Bruker All Set to Take Over the Pre-clinical In-vivo Imaging Business of Carestream. AZoOptics, viewed 23 November 2024, https://www.azooptics.com/News.aspx?newsID=16163.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.